GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » HPGC Renmintongtai Pharmaceutical Corp (SHSE:600829) » Definitions » Cyclically Adjusted FCF per Share

HPGC Renmintongtai Pharmaceutical (SHSE:600829) Cyclically Adjusted FCF per Share : ¥0.16 (As of Mar. 2024)


View and export this data going back to 1994. Start your Free Trial

What is HPGC Renmintongtai Pharmaceutical Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

HPGC Renmintongtai Pharmaceutical's adjusted free cash flow per share for the three months ended in Mar. 2024 was ¥-0.582. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is ¥0.16 for the trailing ten years ended in Mar. 2024.

During the past 12 months, HPGC Renmintongtai Pharmaceutical's average Cyclically Adjusted FCF Growth Rate was 14.30% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 13.60% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was -8.60% per year. During the past 10 years, the average Cyclically Adjusted FCF Growth Rate was -4.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of HPGC Renmintongtai Pharmaceutical was 23.30% per year. The lowest was -29.90% per year. And the median was 4.30% per year.

As of today (2024-06-08), HPGC Renmintongtai Pharmaceutical's current stock price is ¥5.97. HPGC Renmintongtai Pharmaceutical's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was ¥0.16. HPGC Renmintongtai Pharmaceutical's Cyclically Adjusted Price-to-FCF of today is 37.31.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of HPGC Renmintongtai Pharmaceutical was 320.00. The lowest was 17.78. And the median was 50.16.


HPGC Renmintongtai Pharmaceutical Cyclically Adjusted FCF per Share Historical Data

The historical data trend for HPGC Renmintongtai Pharmaceutical's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HPGC Renmintongtai Pharmaceutical Cyclically Adjusted FCF per Share Chart

HPGC Renmintongtai Pharmaceutical Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.18 0.15 0.11 0.13 0.22

HPGC Renmintongtai Pharmaceutical Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.14 0.13 0.15 0.22 0.16

Competitive Comparison of HPGC Renmintongtai Pharmaceutical's Cyclically Adjusted FCF per Share

For the Drug Manufacturers - Specialty & Generic subindustry, HPGC Renmintongtai Pharmaceutical's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


HPGC Renmintongtai Pharmaceutical's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, HPGC Renmintongtai Pharmaceutical's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where HPGC Renmintongtai Pharmaceutical's Cyclically Adjusted Price-to-FCF falls into.



HPGC Renmintongtai Pharmaceutical Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, HPGC Renmintongtai Pharmaceutical's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.582/115.2271*115.2271
=-0.582

Current CPI (Mar. 2024) = 115.2271.

HPGC Renmintongtai Pharmaceutical Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 0.785 98.200 0.921
201409 0.146 98.900 0.170
201412 -0.222 99.000 -0.258
201503 -0.183 99.900 -0.211
201506 0.144 99.500 0.167
201509 0.318 100.500 0.365
201512 0.236 100.600 0.270
201603 0.009 102.200 0.010
201606 -0.063 101.400 -0.072
201609 -0.219 102.400 -0.246
201612 0.313 102.600 0.352
201703 0.147 103.200 0.164
201706 0.117 103.100 0.131
201709 -0.317 104.100 -0.351
201712 0.281 104.500 0.310
201803 0.318 105.300 0.348
201806 0.049 104.900 0.054
201809 -0.124 106.600 -0.134
201812 0.380 106.500 0.411
201903 -0.518 107.700 -0.554
201906 -0.013 107.700 -0.014
201909 -0.009 109.800 -0.009
201912 -0.184 111.200 -0.191
202003 -0.120 112.300 -0.123
202006 0.028 110.400 0.029
202009 0.022 111.700 0.023
202012 0.030 111.500 0.031
202103 -0.465 112.662 -0.476
202106 0.359 111.769 0.370
202109 -0.331 112.215 -0.340
202112 0.014 113.108 0.014
202203 -0.068 114.335 -0.069
202206 0.278 114.558 0.280
202209 0.110 115.339 0.110
202212 0.198 115.116 0.198
202303 -0.070 115.116 -0.070
202306 0.522 114.558 0.525
202309 -0.192 115.339 -0.192
202312 0.273 114.781 0.274
202403 -0.582 115.227 -0.582

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


HPGC Renmintongtai Pharmaceutical  (SHSE:600829) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

HPGC Renmintongtai Pharmaceutical's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=5.97/0.16
=37.31

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of HPGC Renmintongtai Pharmaceutical was 320.00. The lowest was 17.78. And the median was 50.16.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


HPGC Renmintongtai Pharmaceutical Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of HPGC Renmintongtai Pharmaceutical's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


HPGC Renmintongtai Pharmaceutical (SHSE:600829) Business Description

Traded in Other Exchanges
N/A
Address
No. 76 Hengshan Road, Nangang District, Heilongjiang Province, Harbin, CHN, 150076
HPGC Renmintongtai Pharmaceutical Corp, formerly Harbin Pharm. Group Sanjing Pharmaceutical Shareholding Co Ltd is engaged in the production and sale of pharmaceuticals products in China.
Executives
Yue Xian Zhi senior management
Zhang Li Jun Director

HPGC Renmintongtai Pharmaceutical (SHSE:600829) Headlines

No Headlines